Sagimet Biosciences (SGMT) Accumulated Expenses: 2023-2024
Historic Accumulated Expenses for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $2.8 million.
- Sagimet Biosciences' Accumulated Expenses fell 12.95% to $2.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.8 million, marking a year-over-year decrease of 12.95%. This contributed to the annual value of $5.4 million for FY2023, which is N/A change from last year.
- Per Sagimet Biosciences' latest filing, its Accumulated Expenses stood at $2.8 million for Q3 2024, which was down 21.14% from $3.6 million recorded in Q2 2024.
- Sagimet Biosciences' Accumulated Expenses' 5-year high stood at $5.4 million during Q4 2023, with a 5-year trough of $2.4 million in Q2 2023.
- Over the past 2 years, Sagimet Biosciences' median Accumulated Expenses value was $3.4 million (recorded in 2023), while the average stood at $3.6 million.
- The largest annual percentage gain for Sagimet Biosciences' Accumulated Expenses in the last 5 years was 47.73% (2024), contrasted with its biggest fall of 12.95% (2024).
- Quarterly analysis of 2 years shows Sagimet Biosciences' Accumulated Expenses stood at $5.4 million in 2023, then decreased by 12.95% to $2.8 million in 2024.
- Its last three reported values are $2.8 million in Q3 2024, $3.6 million for Q2 2024, and $4.0 million during Q1 2024.